about
N-terminal splice variants of the type I PACAP receptor: isolation, characterization and ligand binding/selectivity determinantsPACAP type I receptor transactivation is essential for IGF-1 receptor signalling and antiapoptotic activity in neurons.Neuroprotective roles of pituitary adenylate cyclase-activating polypeptide in neurodegenerative diseases.Regulation of olfactory neurogenesis by amidated neuropeptides.Augmented cystine-glutamate exchange by pituitary adenylate cyclase-activating polypeptide signaling via the VPAC1 receptor.Structural and morphometric comparison of the molar teeth in pre-eruptive developmental stage of PACAP-deficient and wild-type mice.STC1 induction by PACAP is mediated through cAMP and ERK1/2 but not PKA in cultured cortical neuronsPituitary adenylate cyclase-activating polypeptide inhibits transforming growth factor-beta1-induced apoptosis in a human pituitary adenoma cell line.Reactive oxygen species and inhibitors of inflammatory enzymes, NADPH oxidase, and iNOS in experimental models of Parkinson's disease.Convergent phosphomodulation of the major neuronal dendritic potassium channel Kv4.2 by pituitary adenylate cyclase-activating polypeptide.Mapping the active site in vasoactive intestinal peptide to a core of four amino acids: neuroprotective drug designImpaired nerve regeneration and enhanced neuroinflammatory response in mice lacking pituitary adenylyl cyclase activating peptide.Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brainEffect of PACAP in central and peripheral nerve injuries.Pituitary adenylate cyclase-activating polypeptide counteracts the impaired adult neural stem cell viability induced by palmitate.Isolation of peptide transport system-6 from brain endothelial cells: therapeutic effects with antisense inhibition in Alzheimer and stroke models.Current disease modifying approaches to treat Parkinson's disease.Protein kinase A-dependent substance P expression by pituitary adenylate cyclase-activating polypeptide in rat sensory neuronal cell line ND7/23 cells.Effects of PACAP on oxidative stress-induced cell death in rat kidney and human hepatocyte cells.Expression, purification, and reconstitution of receptor for pituitary adenylate cyclase-activating polypeptide. large-scale purification of a functionally active G protein-coupled receptor produced in Sf9 insect cells.Intranasal administration of PACAP: uptake by brain and regional brain targeting with cyclodextrins.Changes in pituitary adenylate cyclase-activating Peptide 27-like immunoreactive nervous structures in the porcine descending colon during selected pathological processes.Examination of calcium-binding protein expression in the inner ear of wild-type, heterozygous and homozygous pituitary adenylate cyclase-activating polypeptide (PACAP)-knockout mice in kanamycin-induced ototoxicity.Activation of Trk neurotrophin receptor signaling by pituitary adenylate cyclase-activating polypeptides.Fibroblast growth factor-2 converts PACAP growth action on embryonic hindbrain precursors from stimulation to inhibition.Pituitary adenylate cyclase-activating polypeptide enhances saliva secretion via direct binding to PACAP receptors of major salivary glands in mice.Protection against developmental retardation in apolipoprotein E-deficient mice by a fatty neuropeptide: implications for early treatment of Alzheimer's disease.Comparative examination of inner ear in wild type and pituitary adenylate cyclase activating polypeptide (PACAP)-deficient mice.VIP and PACAP 38 modulate ibotenate-induced neuronal heterotopias in the newborn hamster neocortex.Structural and Morphometric Comparison of Lower Incisors in PACAP-Deficient and Wild-Type Mice.
P2860
Q28139403-E002A1DB-D519-4FD2-8AFD-B74B4FDAC248Q33276406-4077CE6B-4E60-4311-8290-C42BEACF1AB9Q34179881-AD2FD8EE-CB72-4BBC-B837-583ED9D72324Q34400306-C5C88712-5A5B-4010-AC70-14438A11702DQ35024151-F1DB11C8-CFBA-486B-A17E-0DD2012CD31CQ35223032-8C096C5D-BDE0-4163-9D17-0C019A3840FCQ35667237-F8E4EC24-7043-4D6A-860E-4A2224C2A811Q35787965-7863705D-FB0D-4FC0-BE43-5CD463DEF517Q35942562-0F5953A4-2375-4E98-933E-B6BBEA076830Q36378257-1B3DA062-C2B2-4E26-A66D-41AD49E98D15Q36460261-A6A6AEDE-DDBA-4892-ACC5-07F482D0F0C5Q36464494-CA3A80B5-2319-48B2-B904-D57FF04D50F0Q37370085-D3BF2DE5-158E-4BF4-B2F9-73F658646463Q38040105-9A42E648-C8DD-46D2-8ED1-D4160358D72CQ38329342-9723BCBD-E8AC-4FA5-BC1A-16FF97AF15C8Q38359110-8ABD2057-4BFF-4AA4-822D-758F0A9CF6F9Q38652153-3987072F-986D-41EF-882C-7663C537F37AQ39379630-76F1B867-0789-4D11-AC07-FF2E4C3EDFCEQ39672838-BB16BA28-EA53-421B-9AD6-F69D5F88145AQ41032335-F9A455F1-43C2-4F8C-8D07-656EB84AA204Q42274137-DC3AC1D7-D083-4A1D-B53C-78D1D0B04943Q43582500-5E6B8C9E-3FB5-4CBB-881A-528B7FFCAC69Q43812646-6EAAAD37-C0FD-48AE-838E-0BD9018B2DBCQ43850091-19721A44-2FF1-4A86-97FE-5AD2841843BFQ43916537-1908077B-BA9D-4502-9CD4-72AF563193CEQ48051037-A41C9897-DFC2-4565-B2ED-702A0AFFE566Q48627726-AE91267D-B605-45FC-9056-835C981CD66BQ48744942-BC47B903-FF3F-4E38-9596-5EB8AB35C807Q49115803-B8206D91-640C-4F8F-AE24-7115DB4A6E45Q53106362-FF971E1B-B736-4769-B51D-4F7558D47157
P2860
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
PACAP functions as a neurotrophic factor.
@en
type
label
PACAP functions as a neurotrophic factor.
@en
prefLabel
PACAP functions as a neurotrophic factor.
@en
P2093
P2860
P1476
PACAP functions as a neurotrophic factor.
@en
P2093
Brenneman DE
Somogyvari-Vigh A
P2860
P304
P356
10.1111/J.1749-6632.1994.TB19825.X
P407
P577
1994-10-01T00:00:00Z